Best Professional Development Grants for Nonprofits in Alaska

The DoW Bone Marrow Failure Idea Development Award supports innovative, high-impact research aimed at understanding and curing bone marrow failure diseases. This grant is available to both Established Investigators and Early-Career Investigators, with no preliminary data required for applications. Reviewers assess proposals based on specific criteria tailored to the investigator's career stage. The focus is on achieving interpretable results that contribute significantly to the field.

The DoW Bone Marrow Failure Investigator-Initiated Research Award supports innovative research aimed at advancing the understanding and treatment of bone marrow failure. This funding opportunity encourages applications for translational and clinical studies, requiring preliminary data to strengthen proposals. Unique features include the ability for a partnering Principal Investigator to contribute to the research, thereby fostering collaboration while maintaining a focus on significant advancements in patient care.

The FY26 Duchenne Muscular Dystrophy Research Program's Idea Development Award promotes innovative, high-risk research aimed at advancing treatment for Duchenne muscular dystrophy (DMD). It encourages projects with a strong scientific basis and feasibility, focusing on therapies that work across all ages, including infants and nonambulatory patients. Eligible applicants include experienced and transitioning investigators, fostering diverse expertise to enhance DMD research and improve patient outcomes.

The FY26 Duchenne Muscular Dystrophy Research Program's Clinical/Translational Research Award supports pivotal research aimed at translating innovative therapeutic strategies into clinical applications for Duchenne muscular dystrophy (DMD). Two funding levels cater to diverse project complexities, along with a Partnering PI Option promoting collaboration between early-career and established investigators. This initiative emphasizes the integration of preliminary data and encourages pilot trials to advance DMD therapies effectively.

The FY26 Bone Marrow Failure Research Program's Resource Development Award aims to create a multiomic atlas from human bone marrow failure samples. This resource will be open-access, providing essential data for researchers and clinicians to enhance their understanding of bone marrow failure diseases. A comprehensive Data Resource Sharing Plan is required to ensure timely availability of the developed resource, fostering collaboration within the scientific community.

The FY26 Parkinson’s Research Program Investigator-Initiated Research Award supports innovative, multidisciplinary research projects aimed at advancing the understanding and treatment of Parkinson’s disease. The award encourages collaboration among multiple principal investigators, requiring preliminary data and allowing clinical trials to enhance research outcomes. This initiative is vital for fostering impactful discoveries within the four specified focus areas of the program, ultimately improving patient care and management.

The FY26 Parkinson’s Research Program (PRP) Early Investigator Research Award supports early-career researchers in Parkinson’s disease (PD) research. It offers two funding levels: Level 1 for fellows requiring a Mentor and Level 2 for independent investigators. The PI must show potential in PD research, with Level 1 emphasizing mentorship and Level 2 needing preliminary data. Research must align with one of the four FY26 PRP Focus Areas, excluding clinical trials.

The DOW Combat Readiness – Medical Research Program's FY26 Translational Research Award supports innovative research aimed at improving trauma care outcomes. This program emphasizes hypothesis-driven studies that can transition promising technologies into practical solutions for enhancing casualty survivability. Applicants must provide preliminary data and utilize validated animal models, with a focus on projects that meet a minimum technology readiness level of 4, ensuring a mature translational research effort.

The National Institute of Allergy and Infectious Diseases (NIAID) is advancing research on immune tolerance through its Collaborative Network. This program aims to clarify the mechanisms of immune tolerance and develop interventions for related diseases, including transplant rejection and autoimmune disorders. Key objectives include conducting clinical trials on tolerogenic strategies and refining immune assays. This initiative is supported by regulations under the Public Health Service Act, ensuring a structured approach to improving patient outcomes.

The Translational Transplantation Tolerance Cooperative Study Group, supported by the National Institute of Allergy and Infectious Diseases, aims to advance transplant tolerance strategies that promote long-term graft survival without lifelong immunosuppression. This initiative focuses on developing, optimizing, and evaluating methods to induce immune tolerance in allogeneic transplants through collaborative efforts across multiple centers, utilizing translationally relevant models to ensure effective outcomes.

The National Institute of Allergy and Infectious Diseases (NIAID) is advancing organ transplantation outcomes through the Clinical Trials in Organ Transplantation in Children and Adults (CTOT-CA) program. This initiative supports multicenter clinical trials and mechanistic studies related to heart, lung, kidney, liver, and intestinal transplants, as well as non-hematopoietic cellular transplantation. By exploring immune mechanisms and innovative therapies, the program aims to enhance the success and efficacy of organ transplantation.

The National Cancer Institute (NCI) invites applications for the validation of biomarkers and assays for cancer detection and treatment. This funding opportunity allows for biphasic or monophasic applications to support both analytical and clinical validation phases. Successful projects will leverage human specimens to develop assays that enhance cancer treatment and prevention, ensuring multidisciplinary collaboration among scientists and clinicians. This initiative aims to improve cancer management through reliable and clinically validated tools.

The Roesler, Max and Elizabeth Memorial Scholarship Fund supports non-traditional students aged 25 and older in Noble County, Indiana, pursuing higher education or retraining. This fund awards $1,500 to applicants enrolled in any accredited college, university, or trade school. Applicants may be full-time or part-time students and may reapply. The scholarship reflects the commitment of generous donors to invest in local students' educational goals.

The Linda Tilghman Healthcare Scholarship supports Noble County high school seniors enrolled in the Primary Healthcare Program at Impact Institute. Applicants must pursue a degree in healthcare and maintain a minimum GPA of 2.50. This one-time $1,000 award can be used for tuition and academic fees. To apply, students must submit an essay on their healthcare outlook and provide a reference from a teacher or employer. Funds not used for educational purposes must be returned.

Pfizer is launching a grant initiative to enhance care for patients with advanced ALK+ non-small cell lung cancer (NSCLC). This program aims to support independent medical education projects focusing on patient and caregiver preparation for ALK inhibitor therapy, side-effect management, and the development of resources that promote informed decision-making and accessibility. By addressing the challenges faced by this patient population, the initiative seeks to improve treatment outcomes and quality of life.

Pfizer, in collaboration with the American Headache Society, invites innovative proposals for quality improvement initiatives targeting gaps in headache medicine. The focus is on enhancing patient outcomes through effective diagnosis, treatment, and management strategies, as well as education in medical training. This grant aims to develop widely usable tools and information that promote patient-centered care and equity for those affected by migraine and headache disorders.

The Universal Application for Adults offers a simplified way for adult students in Elkhart County to apply for six different scholarships with one application. This initiative by the Community Foundation aims to support those pursuing further education, whether returning to school or changing careers. Eligible applicants must have a high school diploma and plan to attend an accredited institution. This program streamlines the scholarship process, making it easier for dedicated learners to access funding opportunities.

The Grady Graves Scholarship Fund, established in 1953, aims to uplift the community by providing scholarships of up to $20,000 for graduating seniors of Crowell High School in Texas. Focused on enhancing health, wealth, and education, this initiative fosters a culture of giving and equity. By partnering with local donors and organizations, the fund plays a vital role in shaping a brighter future for students and the broader community.

GBA1 Parkinson's Disease Research Catalyst Program

The GBA1-PD Research Catalyst Program seeks to build a deeper, globally integrated understanding of GBA1-associated Parkinson’s disease by aligning efforts across geographies and maximizing the value of shared datasets and research assets. Funding will support hypothesis- driven projects with an emphasis on integrative, cross-cohort analyses and the systematic characterization and standardization of models to enable broad use by the research community.

Funding

Duration: 12 to 24 months

Award Amount: Up to $300,000. Requested support should be commensurate with work proposed.

These budgets include direct and indirect costs. For academic and for-profit institutions, no more than 15% or 10%, respectively, may go to indirect costs. 

The Jack Ford Shelby Scholarship Fund, established in 1953, supports graduating seniors from Littlefield High School in Texas with scholarships up to $5,000 for pursuing a baccalaureate degree at accredited colleges or universities. This initiative aims to enhance community health and equity by investing in the education of local students, ensuring they have the necessary resources to succeed academically and contribute positively to society.

Accelerating the Development of Combined CGM–Pump Devices

A combined continuous glucose monitor (CGM) and insulin pump device represents an innovative approach to simplifying diabetes management by integrating two essential technologies into a single device. This approach has the potential to improve quality of life for people with type 1 diabetes (T1D) by reducing the burden associated with wearing and managing multiple devices.

Despite this promise, the development of combined CGM–pump devices presents technical and commercialization challenges. These include the need for further advances in device compatibility and lifespan, system reliability, and scalable manufacturing, while maintaining affordability and broadaccessibility. In addition, a potential insulin dilution effect may require adjustment of the CGM algorithm.

Breakthrough T1D invites applications for research and development projects that address key technical, clinical, and translational challenges related to combined CGM–pump devices, with the goal of accelerating their development and improving outcomes for people living with T1D.

In response to this announcement, applications may request up to a total of $900,000 USD for up to three years. 

The Emerge Grant, established by the Jeannette Rankin Foundation, supports women and nonbinary individuals aged 25 and older from Georgia and Montana. With grants up to $2,500 annually, recipients can pursue technical, vocational, or degree programs at accredited U.S. institutions. This initiative, rooted in Rankin's legacy, aims to empower those demonstrating financial need. Applicants will be informed about their status, ensuring transparency in the selection process.

The Jeannette Rankin National Scholar Grant supports women and nonbinary students aged 35 and older, providing up to $2,500 annually for technical or vocational education, associate’s degrees, or first bachelor’s degrees. This grant, renewable for up to five years, aims to empower those facing financial need, fostering better futures for American women. Recipients are selected based on their applications, ensuring that all candidates are informed about their status.

The CTTSS Graduate Students Research Award, offered by the Society of Toxicology, recognizes outstanding research by current Ph.D. students in translational and clinical toxicology. Recipients are announced at the SOT Annual Meeting, with the first-place winner receiving a cash award and certificate. This award aims to encourage innovation and academic growth among graduate students in the field of toxicology, enhancing the impact of their research on human, animal, and environmental health.

AD Osherman Scholarship

Benefiting first-generation students in Texas.

Funding

Four (4) scholarships awarded out:

• $3,500 for students pursuing a 4-year degree
• $2,500 for students pursuing a 2-year degree

One-time award. Previous recipients may reapply as long as all eligibility requirements are met.

Camillo Family Scholarship 

Benefiting dependents of Camillo Properties, Camcorp Entities, or LCI Services employees.

The Camillo Family Scholarship was created to provide dependents of employees of Camillo Companies (Camillo Holdings, LCI Services, Legend Homes, Millmark Capital, and SimplyHome) with scholarships to further their education.

This is a renewable scholarship, meaning recipients can renew the award and claim up to 4 years of funding if they meet the GPA and enrollment requirements and complete the renewal application for each academic year they plan to be enrolled.

Multiple scholarships awarded for the 2026-27 academic year. Award amount varies by college/degree type:

• 4-Year College/University - The scholarship is comprised of up to four annual awards of $5,000, for a total award of up to $20,000. The four annual awards may be received over a period of up to five years.
• 2-Year College/Trade School - The scholarship award is comprised of up to two annual awards of $2,500, for a total award of up to $5,000. The two annual awards may be received over a period of up to three years.

What can the scholarship be used for?

The scholarship will be mailed directly to the student's college to be used towards tuition, required academic fees, and/or book expenses. 

Scholarship funding cannot be distributed directly to the student.